MediPharm Labs Corp. (LABS.TO)
CAD 0.06
(-7.69%)
CAD 0.06
(-7.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -18.25 Million CAD | 36.11% |
| 2022 | -29.53 Million CAD | 39.63% |
| 2021 | -48.91 Million CAD | 32.6% |
| 2020 | -72.57 Million CAD | -1146.07% |
| 2019 | 6.93 Million CAD | 186.43% |
| 2018 | -8.02 Million CAD | -746.73% |
| 2017 | -948 Thousand CAD | -607.8% |
| 2016 | -133.93 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.37 Million CAD | 38.35% |
| 2024 Q1 | -3.84 Million CAD | -14.64% |
| 2023 FY | -18.86 Million CAD | 36.11% |
| 2023 Q4 | -3.35 Million CAD | 23.01% |
| 2023 Q3 | -4.35 Million CAD | 42.92% |
| 2023 Q2 | -7.62 Million CAD | -128.89% |
| 2023 Q1 | -3.33 Million CAD | 20.11% |
| 2022 Q1 | -7.5 Million CAD | 66.14% |
| 2022 FY | -29.53 Million CAD | 39.63% |
| 2022 Q4 | -4.17 Million CAD | 48.15% |
| 2022 Q3 | -8.04 Million CAD | 11.28% |
| 2022 Q2 | -9.06 Million CAD | -20.86% |
| 2021 FY | -48.91 Million CAD | 32.6% |
| 2021 Q4 | -22.16 Million CAD | -197.28% |
| 2021 Q3 | -7.45 Million CAD | 34.48% |
| 2021 Q2 | -11.38 Million CAD | -43.78% |
| 2021 Q1 | -7.91 Million CAD | 73.07% |
| 2020 Q3 | -16.74 Million CAD | -271.58% |
| 2020 Q2 | -4.5 Million CAD | 79.45% |
| 2020 Q1 | -21.93 Million CAD | -776.35% |
| 2020 FY | -72.57 Million CAD | -1146.07% |
| 2020 Q4 | -29.38 Million CAD | -75.49% |
| 2019 FY | 6.93 Million CAD | 186.43% |
| 2019 Q3 | 5.36 Million CAD | 26.92% |
| 2019 Q2 | 4.22 Million CAD | 2880.92% |
| 2019 Q1 | -152 Thousand CAD | -117.12% |
| 2019 Q4 | -2.5 Million CAD | -146.65% |
| 2018 Q4 | 888 Thousand CAD | 947.38% |
| 2018 Q2 | -11.94 Thousand CAD | 94.26% |
| 2018 Q1 | -208.27 Thousand CAD | -849.45% |
| 2018 FY | -8.02 Million CAD | -746.73% |
| 2018 Q3 | -104.79 Thousand CAD | -777.0% |
| 2017 FY | -948 Thousand CAD | -607.8% |
| 2017 Q3 | -39.78 Thousand CAD | -29.34% |
| 2017 Q2 | -30.76 Thousand CAD | 71.12% |
| 2017 Q1 | -106.52 Thousand CAD | 0.0% |
| 2017 Q4 | -21.93 Thousand CAD | 44.86% |
| 2016 FY | -133.93 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -46.45 Million CAD | 60.709% |
| Avicanna Inc. | -7.93 Million CAD | -130.077% |
| Avant Brands Inc. | -1.45 Million CAD | -1157.891% |
| Cardiol Therapeutics Inc. | -29.78 Million CAD | 38.722% |
| Crescita Therapeutics Inc. | -1.95 Million CAD | -833.129% |
| Knight Therapeutics Inc. | -2.89 Million CAD | -531.557% |
| OrganiGram Holdings Inc. | -242.73 Million CAD | 92.481% |
| Canopy Growth Corporation | -228.71 Million CAD | 92.02% |
| Willow Biosciences Inc. | -13.18 Million CAD | -38.462% |
| Auxly Cannabis Group Inc. | -19 Million CAD | 3.962% |